The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population

被引:16
作者
Laine, AP
Hermann, R
Knip, M
Simell, O
Åkerblom, HK
Ilonen, J
机构
[1] JDRF Ctr Prevent Type Diabet 1, Turku, Finland
[2] Univ Turku, Dept Virol, Turku, Finland
[3] Univ Turku, Dept Paediat, Turku, Finland
[4] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland
[5] Tampere Univ Hosp, Dept Paediat, Tampere, Finland
来源
TISSUE ANTIGENS | 2004年 / 63卷 / 01期
关键词
association studies; Finnish population; HLA region; insulin gene region; type; 1; diabetes;
D O I
10.1111/j.1399-0039.2004.00153.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In addition to the known human leukocyte antigen (HLA)-associated risk, polymorphisms of insulin gene region show association with type 1 diabetes. We analyzed possible interactions between the HLA class II genotypes and -2221 MspI (insulin) INS gene polymorphism in Finnish population, using a series of 1331 diabetic children and 2222 healthy newborns. C/C genotype was increased among diabetic children compared to the controls (83.2 vs 70.1%). This genotype was slightly more common in diabetic children with low or moderate HLA-associated risk than in those with high risk, but INS gene effect was clear in all major HLA-risk genotypes and, thus, can be used as an additional risk prediction marker, irrespective of HLA genotypes.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 10 条
[1]   INSULIN GENE REGION-ENCODED SUSCEPTIBILITY TO TYPE-1 DIABETES IS NOT RESTRICTED TO HLA-DR4-POSITIVE INDIVIDUALS [J].
BAIN, SC ;
PRINS, JB ;
HEARNE, CM ;
RODRIGUES, NR ;
ROWE, BR ;
PRITCHARD, LE ;
RITCHIE, RJ ;
HALL, JRS ;
UNDLIEN, DE ;
RONNINGEN, KS ;
DUNGER, DB ;
BARNETT, AH ;
TODD, JA .
NATURE GENETICS, 1992, 2 (03) :212-215
[2]   A POLYMORPHIC LOCUS NEAR THE HUMAN INSULIN GENE IS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BELL, GI ;
HORITA, S ;
KARAM, JH .
DIABETES, 1984, 33 (02) :176-183
[3]   SUSCEPTIBILITY TO HUMAN TYPE-1 DIABETES AT IDDM2 IS DETERMINED BY TANDEM REPEAT VARIATION AT THE INSULIN GENE MINISATELLITE LOCUS [J].
BENNETT, ST ;
LUCASSEN, AM ;
GOUGH, SCL ;
POWELL, EE ;
UNDLIEN, DE ;
PRITCHARD, LE ;
MERRIMAN, ME ;
KAWAGUCHI, Y ;
DRONSFIELD, MJ ;
POCIOT, F ;
NERUP, J ;
BOUZEKRI, N ;
CAMBONTHOMSEN, A ;
RONNINGEN, KS ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE GENETICS, 1995, 9 (03) :284-292
[4]   Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion [J].
Halminen, M ;
Veijola, R ;
Reijonen, H ;
Ilonen, J ;
Akerblom, HK ;
Knip, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) :847-852
[5]   INSULIN-IGF2 REGION ON CHROMOSOME-11P ENCODES A GENE IMPLICATED IN HLA-DR4-DEPENDENT DIABETES SUSCEPTIBILITY [J].
JULIER, C ;
HYER, RN ;
DAVIES, J ;
MERLIN, F ;
SOULARUE, P ;
BRIANT, L ;
CATHELINEAU, G ;
DESCHAMPS, I ;
ROTTER, JI ;
FROGUEL, P ;
BOITARD, C ;
BELL, JI ;
LATHROP, GM .
NATURE, 1991, 354 (6349) :155-159
[6]   HLA class II associated risk and protection against multiple sclerosis -: a Finnish family study [J].
Laaksonen, M ;
Pastinen, T ;
Sjöroos, M ;
Kuokkanen, S ;
Ruutiainen, J ;
Sumelahti, ML ;
Reijonen, H ;
Salonen, R ;
Wikström, J ;
Panelius, M ;
Partanen, J ;
Tienari, PJ ;
Ilonen, J .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 122 (1-2) :140-145
[7]  
METCALFE KA, 1995, DIABETOLOGIA, V38, P1223, DOI 10.1007/BF00422373
[8]   Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland:: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci [J].
Nejentsev, S ;
Sjöroos, M ;
Soukka, T ;
Knip, M ;
Simell, O ;
Lövgren, T ;
Ilonen, J .
DIABETIC MEDICINE, 1999, 16 (12) :985-992
[9]   The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes [J].
Pugliese, A ;
Zeller, M ;
Fernandez, A ;
Zalcberg, LJ ;
Bartlett, RJ ;
Ricordi, C ;
Pietropaolo, M ;
Eisenbarth, GS ;
Bennett, ST ;
Patel, DD .
NATURE GENETICS, 1997, 15 (03) :293-297
[10]  
UNDLIEN DE, 1994, DIABETOLOGIA, V37, P745, DOI 10.1007/s001250050174